New test opens prenatal genetic diagnosis to all
A non-invasive test which allows faster, cheaper, and less risky prenatal genetic screening was announced by Australian researchers at the International Genetics Congress in Melbourne today.
The new test can also be performed much earlier in pregnancy, say its developers Dr Ian Findlay and Mr Darryl Irwin of the Australian Genome Research Facility in Brisbane. It should open the opportunity of prenatal genetic testing to a wider group of women. “This test will focus conventional prenatal testing much more effectively,” said Dr Findlay.
The new test is based around PAP smears of the type normally taken for cancer screening. Cells from the foetus are isolated, genetically identified, and screened for a wide range of abnormalities such as Down syndrome and cystic fibrosis.
Current prenatal tests, such as amniocentesis and chorionic villus sampling, involve putting a needle into the womb to obtain fluid. This carries with it about a one per cent chance of miscarriage. The risk of miscarriage and the high cost of testing mean that these invasive techniques are offered only to mothers over 35 or those at high risk. And only one in 20 indicate an affected pregnancy.
Because only older women are tested, about 80% of Down syndrome pregnancies in younger mothers in Australia are currently not identified. The new prenatal test can safely be offered to all pregnant women. It also ensures that invasive tests, with the associated miscarriage risk, are only performed when necessary for confirmation.
A further advantage of the new test is that it can be easily performed by general practitioners. The samples can then be sent to laboratories through the post for analysis, allowing greater access to prenatal testing in rural Australia and worldwide.
The study which led to the new test, undertaken in Brisbane hospitals, collected PAP samples from 600 women who were between 5 and 35 weeks pregnant. The research team now hopes to perform testing much earlier in pregnancy, giving couples more time to make informed choices. Current amniocentesis testing is performed between 16 and 20 weeks of pregnancy with results taking 2 to 3 weeks. The researchers hope this new PAP technique can be performed as early as 5 weeks with results being available the same day. The new test is also likely to be less costly than conventional techniques which should increase the accessibility of prenatal testing for all.
“For the first time prenatal testing can be offered to all women,” Mr Irwin said. He is currently completing his PhD at the University of Queensland with Dr Findlay.
While foetal cells have been identified in the cervix for many years, this is the first time they have been efficiently isolated from PAP smears. These cells are then DNA fingerprinted using PCR techniques to confirm their foetal origin unequivocably. Genetic diagnosis can be undertaken in the same test. PCR and SNP techniques which can identify tiny changes in the genetic code allow a much wider range of tests to be performed than conventional prenatal techniques. Clinical trials are progressing and it is hoped that this test will be available within 2 or 3 years.
For further information, contact Mr Darryl Irwin on 0412 779 528 or Dr Ian Findlay on 0402 979 983
Niall Byrne | Internat. Congress of Genetics
The most recent press releases about innovation >>>
Die letzten 5 Focus-News des innovations-reports im Überblick:
In recent years, lasers with ultrashort pulses (USP) down to the femtosecond range have become established on an industrial scale. They could advance some applications with the much-lauded “cold ablation” – if that meant they would then achieve more throughput. A new generation of process engineering that will address this issue in particular will be discussed at the “4th UKP Workshop – Ultrafast Laser Technology” in April 2017.
Even back in the 1990s, scientists were comparing materials processing with nanosecond, picosecond and femtosesecond pulses. The result was surprising:...
Mapping the interaction of a single atom with a single photon may inform design of quantum devices
Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...
A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.
Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...
In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.
“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...
The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.
The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...